![Glenda S. Overbeck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Glenda S. Overbeck
Direttore/Membro del Consiglio presso
Oncovance Technologies, Inc.
Profilo
Glenda S.
Overbeck is currently a Director at Oncovance Technologies, Inc. and Prokaryon Technologies, Inc. She previously worked as a Vice President at BCM Technologies, Inc. from 2000 to 2009.
She also held positions as an Associate at Houston Partners and as a Principal at Progression Therapeutics, Inc. Ms. Overbeck obtained her undergraduate degree and an MBA from Pittsburg State University.
Posizioni attive di Glenda S. Overbeck
| Società | Posizione | Inizio |
|---|---|---|
Oncovance Technologies, Inc.
 Oncovance Technologies, Inc. Information Technology ServicesTechnology Services Provides information management and analytical services | Direttore/Membro del Consiglio | 18/08/2009 |
Prokaryon Technologies, Inc.
 Prokaryon Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets products to prevent and control infectious diseases in animals | Direttore/Membro del Consiglio | 17/08/2009 |
Precedenti posizioni note di Glenda S. Overbeck
| Società | Posizione | Fine |
|---|---|---|
BCM Technologies, Inc.
 BCM Technologies, Inc. Investment ManagersFinance BCM Technologies invests in companies located in the United States. The firm focuses on sectors such as medicine, pharmaceutical and life science. It participates in seed and early stage capital transactions. It acts as a lead investor and also makes co-investments. | Investitore di Private Equity | 30/06/2009 |
Houston Partners
 Houston Partners Investment ManagersFinance Acts as an alternative investment manager | Corporate Officer/Principal | 31/12/1999 |
Progression Therapeutics, Inc.
 Progression Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops prognostic tests and therapies for the treatment cancer | Direttore/Membro del Consiglio | 19/08/2009 |
Formazione di Glenda S. Overbeck
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
19
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
BCM Technologies, Inc.
BCM Technologies, Inc. Investment ManagersFinance BCM Technologies invests in companies located in the United States. The firm focuses on sectors such as medicine, pharmaceutical and life science. It participates in seed and early stage capital transactions. It acts as a lead investor and also makes co-investments. | Finance |
Pittsburg State University
 Pittsburg State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Houston Partners
Houston Partners Investment ManagersFinance Acts as an alternative investment manager | Finance |
Oncovance Technologies, Inc.
Oncovance Technologies, Inc. Information Technology ServicesTechnology Services Provides information management and analytical services | Technology Services |
Progression Therapeutics, Inc.
Progression Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops prognostic tests and therapies for the treatment cancer | Health Technology |
Prokaryon Technologies, Inc.
Prokaryon Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets products to prevent and control infectious diseases in animals | Health Technology |
